Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

71.07
Delayed Data
As of 4:00pm ET
 +1.31 / +1.88%
Today’s Change
51.05
Today|||52-Week Range
135.59
+21.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues30.9M41.3M37.7M36.0M
 
 
 
 
 
Cost of Goods Sold279.0K172.0K823.0K280.0K
 
 
 
 
 
Depreciation And Amortization1.1M1.4M1.3M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income29.5M39.8M35.5M34.4M
 
 
 
 
 
General Expenses110.0M106.0M135.3M109.8M
 
 
 
 
 
Research And Development44.2M46.0M56.2M48.7M
 
 
 
 
 
Total Operating Expenses111.4M107.5M137.5M111.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-80.5M-66.2M-99.8M-75.5M
 
 
 
 
 
Extraordinary Charge0.000.00-5.2M0.00
 
 
Interest Expense On Debt7.3M7.4M7.4M7.5M
 
 
 
 
 
Other Expenses1.2M924.0K1.1M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-86.6M-72.6M-111.3M-81.6M
 
 
 
 
 
Net Income-86.6M-72.6M-111.3M-81.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.0M25.1M25.1M25.3M
 
 
 
 
 
Shares To Calculate EPS Diluted25.0M25.1M25.1M25.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.46-$2.89-$4.43-$3.22
 
 
 
 
 
EPS Diluted-$3.46-$2.89-$4.43-$3.22